cafepharma news hand selected daily
get news headlines in your inbox each weekday

Onglyza

Tagged:

Effient and Onglyza Start Slow—And That May Not Be A Bad Thing

InVivo

Login or register to post comments

Tagged:

EU approves AstraZeneca, Bristol diabetes drug

Marketwatch

Login or register to post comments

Tagged:

Effient and Onglyza Launches "Sluggish"; Multaq More Hopeful

BNET Pharma

Login or register to post comments

Tagged:

Onglyza and the Type 2 Diabetes Approval Path: The Map is Still Sketchy

InVivo

Login or register to post comments

Tagged:

New Diabetes Drug Could Give Januvia Stiff Competition

Seeking Alpha

Login or register to post comments

Tagged:

FDA approves new diabetes drug Onglyza

Yahoo/AP

Login or register to post comments

Tagged:

Bristol exec hints of Onglyza launch strategy

Fierce Pharma

Login or register to post comments

Tagged:

Looking for a Sliver of the Me-Too Pie

Motley Fool

Login or register to post comments

Tagged:

AstraZeneca says Onglyza gets positive opinion

Marketwatch

Login or register to post comments

Tagged:

EU panel gives positive recommendation to Bristol-Myers and AstraZeneca's Onglyza for diabetes

Yahoo/AP

Login or register to post comments

New on Cafepharma

Funny or interesting conversations reps hear in the field
Overheard in the Field
Keep up with the latest at cafepharma:
follow us on twitter
GE Healthcare IT
HIV Reps
New message boards
Baxter IT
Pacific Pulmonary Services
Pacific Pulmonary Services IT
New message board category
Pharma IT Boards

<a href="http://finance.yahoo.com">Yahoo! Finance</a><br/><a href="http://finance.yahoo.com/q?s=ABT">Quote for ABT</a>